Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|December 14, 2001
The binary Clostridium botulinum C2 toxin as a protein delivery system: identification of the minimal protein region necessary for interaction of toxin componentsHolger Barth, Robert Roebling, Michaela Fritz, et al.
Plos One|May 19, 2011
Increased resting-state perfusion after repeated encoding is related to later retrieval of declarative associative memoriesGeorg Groen, Alexander N Sokolov, Christina Jonas, et al.
Epilepsy Research|March 10, 2009
Cervical spinal MRI in a patient with a vagus nerve stimulator (VNS)Robert Roebling, Klaus Huch, Jan Kassubek, et al.
Epilepsia|June 4, 2009
Evaluation of cognition, structural, and functional MRI in juvenile myoclonic epilepsyRobert Roebling, Nico Scheerer, Ingo Uttner, et al.
CNS Drugs|August 7, 2025
Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS DisordersKamil Detyniecki, Adam Strzelczyk, Robert Roebling, et al.
Seizure|October 1, 2023
Epidemiology of focal onset seizures in children aged >1 month to 4 years in Europe, United States, and Canada: A literature reviewSusanne Schubert-Bast, Moninder Kaur, Lars Joeres, et al.
Epilepsia|February 24, 2024
Pharmacokinetics of Staccato® alprazolam in healthy adult participants in two phase 1 studies: An open-label smoker study and a randomized, placebo-controlled ethnobridging studyYoshinobu Hayakawa, Chiara Rospo, Ana Paula Bartmann, et al.
British Journal of Clinical Pharmacology|February 1, 2017
Investigation of the predictive validity of laser-EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteersKlaus Schaffler, Laurent B Nicolas, Andreas Borta, et al.
Epilepsia|November 17, 2020
Effects of lacosamide and carbamazepine on lipids in a randomized trialScott Mintzer, Svetlana Dimova, Ying Zhang, et al.
Epilepsia Open|December 18, 2022
Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trialMark Kristof Farkas, Cynthia Beller, Ali Bozorg, et al.
Pageof 2